Home NeuMoDx Molecular

NeuMoDx Molecular

acquired
Series B
Molecular Diagnostics System Developer
Basic
Enterprise Profile

Basic Information

NeuMoDx Molecular is a molecular diagnostics company that fully integrates the entire molecular diagnostic process from "sample to result" using these platforms. The NeuMoDx™ 288 and NeuMoDx™ 96 Molecular Systems are fully automated, continuous random-access analyzers that utilize proprietary NeuDry reagent technology, incorporating magnetic particle affinity capture and real-time polymerase chain reaction (PCR) chemistry into multi-sample microfluidic cartridges. The combination of NeuDry reagent technology with the platform uniquely merges robotics and microfluidics, eliminating waste associated with the need to reformulate lyophilized reagents, thereby increasing throughput and efficiency while enhancing performance.
NeuMoDx Molecular, Inc.
Minnesota,United States of America
15~50 people
January 01, 2012
info@neumodx.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Molecular Diagnostics
Concept
Disease Diagnosis Department of Clinical Laboratory
Application Scenarios
Medical Devices Early Disease Screening